These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 7855692)
21. Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Gonzalez-Porras JR; Graciani IF; Perez-Simon JA; Martin-Sanchez J; Encinas C; Conde MP; Nieto MJ; Corral M Transfusion; 2008 Jul; 48(7):1318-24. PubMed ID: 18422846 [TBL] [Abstract][Full Text] [Related]
22. Allosensitization in patients receiving multiple blood transfusions. Sakhalkar VS; Roberts K; Hawthorne LM; McCaskill DM; Veillon DM; Caldito GC; Cotelingam JD Ann N Y Acad Sci; 2005; 1054():495-9. PubMed ID: 16339705 [TBL] [Abstract][Full Text] [Related]
23. Use of Rh positive blood in emergency situations. Schmidt PJ; Leparc GF; Samia CT Surg Gynecol Obstet; 1988 Sep; 167(3):229-33. PubMed ID: 3137672 [TBL] [Abstract][Full Text] [Related]
24. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil. Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087 [TBL] [Abstract][Full Text] [Related]
25. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Hendrickson JE; Desmarets M; Deshpande SS; Chadwick TE; Hillyer CD; Roback JD; Zimring JC Transfusion; 2006 Sep; 46(9):1526-36. PubMed ID: 16965580 [TBL] [Abstract][Full Text] [Related]
26. [Severe bleeding in a patient with anti-c alloantibodies and a rare Rhesus phenotype treated with compatible erythrocyte concentrate from the blood bank of the Council of Europe]. Sonke GS; Overbeeke MA; de Graaff WE; Elisen MG Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2628-32. PubMed ID: 16355576 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035 [TBL] [Abstract][Full Text] [Related]
28. A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter. Alvarado-Ramy F; Kuehnert MJ; Alonso-Echanove J; Sledge L; Haley NR; Epstein J; Vostal J; Pearson M Transfus Med; 2006 Feb; 16(1):41-8. PubMed ID: 16480438 [TBL] [Abstract][Full Text] [Related]
29. Transfusion-related acute lung injury and leucocyte-reacting antibodies. Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568 [TBL] [Abstract][Full Text] [Related]
30. Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases. Seyfried H; Walewska I Mater Med Pol; 1990; 22(1):21-5. PubMed ID: 2079855 [TBL] [Abstract][Full Text] [Related]
31. Is a prophylactic treatment by erythropoietin relevant to reduce red blood cell transfusion in the pediatric intensive care unit? Liet JM; Paranon S; Baraton L; Dejode JM; Rozé JC Pediatr Crit Care Med; 2006 Nov; 7(6):541-4. PubMed ID: 17006380 [TBL] [Abstract][Full Text] [Related]
32. Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study). Schonewille H; Honohan Á; van der Watering LM; Hudig F; Te Boekhorst PA; Koopman-van Gemert AW; Brand A Transfusion; 2016 Feb; 56(2):311-20. PubMed ID: 26442648 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies. Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842 [TBL] [Abstract][Full Text] [Related]
34. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570 [TBL] [Abstract][Full Text] [Related]
35. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning. Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594 [TBL] [Abstract][Full Text] [Related]
36. [Anti-RH1 (anti-D) alloimmunization after transfusion of platelet concentrates from RH :1 donors]. Duboeuf S; Flourié F; Courbil R; Oriol P; Benamara A; Chartier M; Rigal E; Garraud O Ann Biol Clin (Paris); 2009; 67(3):353-7. PubMed ID: 19411240 [TBL] [Abstract][Full Text] [Related]
37. Alloimmunization to red cells in thalassemics: emerging problem and future strategies. Gupta R; Singh DK; Singh B; Rusia U Transfus Apher Sci; 2011 Oct; 45(2):167-70. PubMed ID: 21856231 [TBL] [Abstract][Full Text] [Related]
39. Erythrocyte rosetting in Plasmodium falciparum malaria--with special reference to the pathogenesis of cerebral malaria. Carlson J Scand J Infect Dis Suppl; 1993; 86():1-79. PubMed ID: 8493454 [TBL] [Abstract][Full Text] [Related]
40. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Tormey CA; Fisk J; Stack G Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]